• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Zaleplon (marketed as Sonata) Information

Sonata is used to treat short-term difficulty in falling asleep. Sonata has been shown to decrease the time to sleep onset for up to 30 days in clinical studies. Sonata has not been shown to increase your total sleep time or decrease the number of times you wake up after falling asleep.

-
-